首页 | 官方网站   微博 | 高级检索  
     

噻吩并吡啶类抗血栓化合物国内专利技术现状
引用本文:龙巧云,孙文倩,李强,韩涛,康蕾,赵雷,张雨,李爱民,徐文亮.噻吩并吡啶类抗血栓化合物国内专利技术现状[J].中国医药导报,2013,10(6):150-152.
作者姓名:龙巧云  孙文倩  李强  韩涛  康蕾  赵雷  张雨  李爱民  徐文亮
作者单位:[1]国家知识产权局专利局专利审查协作北京中心,北京100080 [2]成都九鼎天元知识产权代理有限公司,四川成都610041 [3]PPG涂料(天津)有限公司,天津300457 [4]中国中化股份有限公司,北京100031
摘    要:噻吩并吡啶类药物(主要包括噻氯匹啶、氯吡格雷、普拉格雷等)自20世纪70年代后期一直是预防或治疗由血栓、栓塞物引起的疾病药物领域的研究热点。本文通过介绍和分析国内近年来噻吩并吡啶类抗血栓药物的专利情况,阐述在这一领域的新药开发及相关专利的申请策略,希望能对国内的制药行业提供一点帮助。

关 键 词:噻吩并吡啶  噻氯匹啶  氯吡格雷  普拉格雷  抗血栓

Domestic patent status quo of the thienopyridine class of antithrombotic compounds
LONG Qiaoyun,SUN Wenqian,LI Qiang,HAN Tao,KANG Lei,ZHAO Lei,ZHANG Yu,LI Aimin,XU Wenliang.Domestic patent status quo of the thienopyridine class of antithrombotic compounds[J].China Medical Herald,2013,10(6):150-152.
Authors:LONG Qiaoyun  SUN Wenqian  LI Qiang  HAN Tao  KANG Lei  ZHAO Lei  ZHANG Yu  LI Aimin  XU Wenliang
Affiliation:1.Patent Examination Cooperation Center of the Patent Office of SIPO, Beijing 100080, China; 2.Chengdu Jiuding- tianyuan Intellectual Property Agency Ltd., Sichuan Province, Chengdu 610041, China; 3.PPG Coatings (Tianjin) Co., Ltd, Tianjin 300457, China; 4.Sinochem Corporation, Beijing 100031, China
Abstract:Thienopyridine class of drugs (Ticlopidine, Clopidogrel, Prasugrel, etc.) since the late 1970s has been the prevention or treatment of thrombosis, emboli disease caused by the field of drug research focus. This paper introduces and analyzes the country in recent years the patent situation of the thienopyridine class of antithrombotic drugs on the development of new drugs in this field and related patent application strategy of the domestic pharmaceutical industry to provide the help.
Keywords:Thienopyridine  Ticlopidine  Clopidogrel  Prasugrel  Anti-thrombotic
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号